BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26053480)

  • 1. Merkel Cell Carcinoma Analysis of Outcomes: A 30-Year Experience.
    Liang E; Brower JV; Rice SR; Buehler DG; Saha S; Kimple RJ
    PLoS One; 2015; 10(6):e0129476. PubMed ID: 26053480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Merkel cell carcinoma: identification of prognostic factors unique to tumors located in the head and neck based on analysis of SEER data.
    Smith VA; Camp ER; Lentsch EJ
    Laryngoscope; 2012 Jun; 122(6):1283-90. PubMed ID: 22522673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor location is an independent prognostic factor in head and neck Merkel cell carcinoma.
    Smith VA; MaDan OP; Lentsch EJ
    Otolaryngol Head Neck Surg; 2012 Mar; 146(3):403-8. PubMed ID: 22166964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of host, tumor, diagnostic, and treatment variables on outcomes in a large cohort with Merkel cell carcinoma.
    Asgari MM; Sokil MM; Warton EM; Iyer J; Paulson KG; Nghiem P
    JAMA Dermatol; 2014 Jul; 150(7):716-23. PubMed ID: 24807619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history of merkel cell carcinoma following locoregional recurrence.
    Grotz TE; Tarantola TI; Otley CC; Weaver AL; McGree ME; Jakub JW
    Ann Surg Oncol; 2012 Aug; 19(8):2556-62. PubMed ID: 22453243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Merkel cell carcinoma: Clinical outcome and prognostic factors in 351 patients.
    van Veenendaal LM; van Akkooi ACJ; Verhoef C; Grünhagen DJ; Klop WMC; Valk GD; Tesselaar MET
    J Surg Oncol; 2018 Jun; 117(8):1768-1775. PubMed ID: 29790179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Merkel cell carcinoma: report of 10 cases and review of the literature.
    Akhtar S; Oza KK; Wright J
    J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):755-67. PubMed ID: 11050578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Merkel cell carcinoma: 30-year experience from a single institution.
    Santamaria-Barria JA; Boland GM; Yeap BY; Nardi V; Dias-Santagata D; Cusack JC
    Ann Surg Oncol; 2013 Apr; 20(4):1365-73. PubMed ID: 23208132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in Merkel cell carcinoma: analysis of 240 cases.
    Tarantola TI; Vallow LA; Halyard MY; Weenig RH; Warschaw KE; Grotz TE; Jakub JW; Roenigk RK; Brewer JD; Weaver AL; Otley CC
    J Am Acad Dermatol; 2013 Mar; 68(3):425-32. PubMed ID: 23200197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Merkel cell carcinoma: a clinicopathological study of 34 patients.
    Koljonen V; Böhling T; Granhroth G; Tukiainen E
    Eur J Surg Oncol; 2003 Sep; 29(7):607-10. PubMed ID: 12943628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of survival in neurometastatic Merkel cell carcinoma.
    Harary M; Kavouridis VK; Thakuria M; Smith TR
    Eur J Cancer; 2018 Sep; 101():152-159. PubMed ID: 30071443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Merkel cell carcinoma: an Australian perspective and the importance of addressing the regional lymph nodes in clinically node-negative patients.
    Howle JR; Hughes TM; Gebski V; Veness MJ
    J Am Acad Dermatol; 2012 Jul; 67(1):33-40. PubMed ID: 21996296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Merkel cell carcinoma: prognosis and treatment of patients from a single institution.
    Allen PJ; Bowne WB; Jaques DP; Brennan MF; Busam K; Coit DG
    J Clin Oncol; 2005 Apr; 23(10):2300-9. PubMed ID: 15800320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sentinel node status and immunosuppression: recurrence factors in localized Merkel cell carcinoma.
    Jouary T; Kubica E; Dalle S; Pages C; Duval-Modeste AB; Guillot B; Mansard S; Saiag P; Aubin F; Bedane C; Dalac S; Dompmartin A; Granel-Brocard F; Lok C; Stoebner PE; Lacour JP; Leccia MT; Diallo A; Ezzedine K; Mateus C
    Acta Derm Venereol; 2015 Sep; 95(7):835-40. PubMed ID: 25784178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing tumor thickness is associated with recurrence and poorer survival in patients with Merkel cell carcinoma.
    Lim CS; Whalley D; Haydu LE; Murali R; Tippett J; Thompson JF; Hruby G; Scolyer RA
    Ann Surg Oncol; 2012 Oct; 19(11):3325-34. PubMed ID: 22820936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Merkel cell carcinoma of the forehead area: a literature review and case report.
    Caldarelli C; Autorino U; Iaquinta C; De Marchi A
    Oral Maxillofac Surg; 2019 Sep; 23(3):365-373. PubMed ID: 31342210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.
    Lawenda BD; Arnold MG; Tokarz VA; Silverstein JR; Busse PM; McIntyre JF; Deschler DG; Baldini EH; Kachnic LA
    Ear Nose Throat J; 2008 Nov; 87(11):634-43. PubMed ID: 19006065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: The Dana-Farber experience and meta-analysis of the literature.
    Gupta SG; Wang LC; Peñas PF; Gellenthin M; Lee SJ; Nghiem P
    Arch Dermatol; 2006 Jun; 142(6):685-90. PubMed ID: 16785370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma.
    Garcia-Carbonero R; Marquez-Rodas I; de la Cruz-Merino L; Martinez-Trufero J; Cabrera MA; Piulats JM; Capdevila J; Grande E; Martin-Algarra S; Berrocal A
    Oncologist; 2019 Oct; 24(10):1375-1383. PubMed ID: 30962295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Merkel cell carcinoma of the head and neck: challenges in implementing best practice.
    Dawe N; Sainsbury D; Veeramani S; Ragbir M; Ahmed OA
    Ann Plast Surg; 2015 Jun; 74(6):737-42. PubMed ID: 24401808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.